Abstract
Genomic analysis, from patients with retinal diseases such as retinitis pigmentosa (RP) and congenital night blindness (CNB), has provided convincing evidence that various subtypes of retinal diseases can result from mutations in the gene encoding rod opsin, a protein that binds 11-cis retinal to form the visual pigment, rhodopsin. Over 100 different mutations in this gene have been documented, and shown to co-segregate with autosomal dominant RP (Berson et al., 2002; Farrar et al., 2002; Nour and Naash, 2003) as well as a few other mutations with CNB (Dryja et al., 1993; Sieving et al., 1995; al Jandal et al., 1999). Interestingly when these CNB causing mutations are expressed in COS cells, they constitutively activated transducin in the dark while in the absence of 11-cis retinal (Dryja et al., 1993; Rao et al., 1994; Gross et al., 2003a; Gross et al., 2003b). Thus, the in vitro data suggests that the CNB mutations generate a persistent ‘dark light’ that saturates the rod photocurrent and severely depresses rod sensitivity in a manner similar to that produced by light. One of these CNB mutations resulted from the replacement of glycine at position 90 by aspartic acid (G90D), which has been shown to associate with an unusual trait of congenital stationary night blindness (CSNB) (Sieving et al., 1995).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
al Jandal, N., Farrar, G.J., Kiang, A.S., Humphries, M.M., Bannon, N., Findlay, J.B. et al., 1999, A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness. Hum. Mutat. 13:75–81.
Berson, E.L., Rosner, B., Weigel-DiFranco, C., Dryja, T.P., and Sandberg, M.A., 2002, Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. Invest Ophthalmol. Vis. Sci. 43:3027–3036.
Ding, X.Q., Nour, M., Ritter, L.M., Goldberg, A.F., Fliesler, S.J., and Naash, M.I., 2004, The R172W mutation in peripherin/rds causes a cone-rod dystrophy in transgenic mice. Hum. Mol. Genet. 13:2075–2087.
Dryja, T.P., Berson, E.L., Rao, V.R., and Oprian, D.D., 1993, Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat. Genet. 4:280–283.
Elias, R.V., Sezate, S.S., Cao, W., and McGinnis, J.F., 2004, Temporal kinetics of the light/dark translocation and compartmentation of arrestin and alpha-transducin in mouse photoreceptor cells. Mol. Vis 10:672–681.
Farrar, G.J., Kenna, P.F., and Humphries, P., 2002, On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO J. 21:857–864.
Gross, A.K., Rao, V.R., and Oprian, D.D., 2003a, Characterization of rhodopsin congenital night blindness mutant T94I. Biochemistry 42:2009–2015.
Gross, A.K., Xie, G., and Oprian, D.D., 2003b, Slow binding of retinal to rhodopsin mutants G90D and T94D. Biochemistry 42:2002–2008.
Hardie, R.C., 2003, Phototransduction: shedding light on translocation. Curr. Biol. 13:R775–R777.
Lee, S.J. and Montell, C., 2004, Light-dependent translocation of visual arrestin regulated by the NINAC myosin III. Neuron 43:95–103.
Lem, J., Krasnoperova, N.V., Calvert, P.D., Kosaras, B., Cameron, D.A., Nicolo, M. et al., 1999, Morphological, physiological, and biochemical changes in rhodopsin knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96:736–741.
Mendez, A., Lem, J., Simon, M., and Chen, J., 2003, Light-dependent translocation of arrestin in the absence of rhodopsin phosphorylation and transducin signaling. J. Neurosci. 23:3124–3129.
Naash, M.I., Wu, T.H., Chakraborty, D., Fliesler, S.J., Ding, X.Q., Nour, M. et al., 2004, Retinal abnormalities associated with the G90D mutation in opsin. J. Comp Neurol. 478:149–163.
Nour, M., Ding, X.Q., Stricker, H., Fliesler, S.J., and Naash, M.I., 2004, Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression. Invest Ophthalmol Vis Sci 45:2514–2521.
Nour, M. and Naash, M.I., 2003, Mouse models of human retinal disease caused by expression of mutant rhodopsin. A valuable tool for the assessment of novel gene therapies. Adv. Exp. Med. Biol. 533:173–179.
Rao, V.R., Cohen, G.B., and Oprian, D.D., 1994, Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367:639–642.
Sieving, P.A., Fowler, M.L., Bush, R.A., Machida, S., Calvert, P.D., Green, D.G. et al., 2001, Constitutive “light” adaptation in rods from G90D rhodopsin: a mechanism for human congenital nightblindness without rod cell loss. J. Neurosci. 21:5449–5460.
Sieving, P.A., Richards, J.E., Naarendorp, F., Bingham, E.L., Scott, K., and Alpern, M., 1995, Dark-light: model for nightblindness from the human rhodopsin Gly-90→Asp mutation. Proc. Natl. Acad. Sci. U. S. A. 92:880–884.
Tan, E., Wang, Q., Quiambao, A.B., Xu, X., Qtaishat, N.M., Peachey, N.S. et al., 2001, The relationship between opsin overexpression and photoreceptor degeneration. Invest Ophthalmol. Vis. Sci. 42:589–600.
Whelan, J.P. and McGinnis, J.F. (1988) Light-dependent subcellular movement of photoreceptor proteins. J. Neurosci. Res. 20:263–270.
Zhang, H., Huang, W., Zhang, H., Zhu, X., Craft, C.M., Baehr, W., and Chen, C.K., 2003, Light-dependent redistribution of visual arrestins and transducin subunits in mice with defective phototransduction. Mol. Vis. 9:231–237.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this paper
Cite this paper
Nash, Z.A., Naash, M.I. (2006). Light/Dark Translocation of Alphatransducin in Mouse Photoreceptor Cells Expressing G90D Mutant Opsin. In: Hollyfield, J.G., Anderson, R.E., LaVail, M.M. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 572. Springer, Boston, MA. https://doi.org/10.1007/0-387-32442-9_19
Download citation
DOI: https://doi.org/10.1007/0-387-32442-9_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-28464-4
Online ISBN: 978-0-387-32442-5
eBook Packages: MedicineMedicine (R0)